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Summary
 
Ligation of CCR5 by the CC chemokines RANTES, MIP-1
 
a
 
 or MIP-1
 
b
 
, and of CXCR4 by
the CXC chemokine SDF-1
 
a
 
, profoundly inhibits the replication of HIV strains that use these
 
coreceptors for entry into CD4
 
1
 
 T lymphocytes. The mechanism of entry inhibition is not
known. We found a rapid and extensive downregulation of CXCR4 by SDF-1
 
a
 
 and of
CCR5 by RANTES or the antagonist RANTES(9-68). Confocal laser scanning microscopy
showed that CCR5 and CXCR4, after binding to their ligands, are internalized into vesicles
that qualify as early endosomes as indicated by colocalization with transferrin receptors. Inter-
nalization was not affected by treatment with 
 
Bordetella pertussis
 
 toxin, showing that it is inde-
pendent of signaling via G
 
i
 
-proteins. Removal of SDF-1
 
a
 
 led to rapid, but incomplete surface
reexpression of CXCR4, a process that was not inhibited by cycloheximide, suggesting that
the coreceptor is recycling from the internalization pool. Deletion of the COOH-terminal, cy-
toplasmic domain of CXCR4 did not affect HIV entry, but prevented SDF-1
 
a
 
–induced re-
ceptor downregulation and decreased the potency of SDF-1
 
a
 
 as inhibitor of HIV replication.
Our results indicate that the ability of the coreceptor to internalize is not required for HIV en-
try, but contributes to the HIV suppressive effect of CXC and CC chemokines.
 
E
 
xpression of CD4 is necessary but not sufficient for
productive infection of human cells with HIV (1, 2).
The existence of an additional recognition site was postu-
lated several years ago (3–4), and it was recently shown that
some chemokine receptors fulfill such a function (5–10).
CXCR4 and CCR5 are the major HIV coreceptors (5–7,
10), although similar functions were also reported for
CCR2b and CCR3 (8, 9). It has been shown that the CC
chemokines, RANTES, MIP-1
 
a
 
, and MIP-1
 
b
 
, which are
agonists for CCR5, inhibit entry of primary, non-syncy-
tium–inducing (NSI) strains that are preferentially isolated
at early stages of the infection (11). The CXC chemokine,
SDF-1
 
a
 
, the ligand of CXCR4, inhibits cell fusion and in-
fection by HIV strains of the syncytium-inducing (SI) phe-
notype that are usually isolated at late, symptomatic stages
of the disease (12, 13).
Chemokines act via seven-transmembrane domain re-
ceptors that couple to heterotrimeric G
 
i
 
-proteins. Their anti-
viral activity is thought to depend on competition for the
binding of the HIV envelope (Env) glycoprotein gp120 to
chemokines receptors (14, 15). It has been reported that
mere occupancy of HIV coreceptors by chemokines, in the
absence of G
 
i
 
 protein–mediated signaling, is sufficient for
inhibition of HIV infection. In fact, RANTES inhibits
HIV infection of cells treated with 
 
B. pertussis
 
 toxin, and a
CCR5 antagonist, RANTES(9-68), was shown to prevent
infection by primary NSI isolates (14, 16). The chemokines,
however, could also inhibit viral entry by downregulating
the expression of their receptors which may be endocytosed
upon ligand binding, as previously shown for the IL-8 and
MCP-1 receptors (17, 18). Therefore, we have studied this
process and the effect of receptor uptake on the HIV sup-
pressive activity of chemokines. In this paper we describe a
rapid, profound downregulation of CXCR4 by SDF-1
 
a
 
A. Amara and S. Le Gall contributed equally to this work.
  
140
 
CXCR4 Internalization Inhibits HIV-1 Entry
 
and of CCR5 by RANTES and RANTES(9-68) in differ-
ent cells, and show that the HIV suppressive effect of chemo-
kines is markedly reduced when receptor endocytosis does
not occur.
 
Materials and Methods
 
DNA Expression Vectors, Cells, and Chemokines.
 
The CXCR4
WT expression vector contains the LESTR cDNA (19) cloned in
a pcDNA3 plasmid (InVitrogen, The Netherlands). The CXCR4
 
D
 
Cyt vector was prepared by a PCR-based strategy, by deleting
the last 41 amino acids that correspond to the COOH-terminal
intracytoplasmic domain of CXCR4. A PCR-synthesized CCR5
DNA insert deleted of the stop codon was fused to a red-shifted
variant of the wild-type Green Fluorescent Protein (GFP) in a
pEGFP plasmid (Clontech, CA). All the PCR products were se-
quenced by the dideoxy method. HeLa is a human epithelial cell
line. U373-CD4 LTR lacZ cell clone derived from the human
glioblastoma cell line U373-MG (20), was transduced with hu-
man CD4 and carries an integrated 
 
E. coli
 
 
 
b
 
-galactosidase reporter
gene driven by a HIV-1 LTR. U373-MG cells, contrary to CEM
and HeLa cells, do not express CXCR4 constitutively (21). HeLa-
CCR5-GFP cells (clone P4-C5) were derived from HeLa-CD4
LTR lacZ (clone P4-2) (22) cotransfected with the CCR5-GFP
vector and a plasmid carrying a hygromycin-resistance cassette.
CHO is a chinese hamster epithelial cell line. The CHO-CCR5-
GFP cell clone was established by transfecting the CCR5-GFP
vector that encodes a neomycin resistance gene. The CCR5-
GFP receptor proved to be fully competent to support viral entry
and Env-mediated cell fusion by CCR5-tropic isolates (HIV
 
JR-CSF,
 
HIV
 
YU2, 
 
HIV
 
ADA
 
), both in HeLa-CCR5-GFP cells or in CHO-
CCR5-GFP transiently expressing CD4 (not shown). CEM is a
human lymphoblastoid CD4
 
1
 
 T cell line. Human peripheral
blood mononuclear cells (PBMC) were isolated by Ficoll gradient
centrifugation and depleted of monocytes by plastic adherence at
37
 
8
 
C. SDF-1
 
a
 
, RANTES, and the antagonist RANTES(9-68)
were chemically synthesized by Dr. I. Clark-Lewis (University of
British Columbia, Vancouver, Canada) (23).
 
Indirect Immunofluorescence Staining.
 
CHO- and HeLa-CCR5-
GFP cells were cultured on glass coverslips in 24-well plates. CEM
cells were seeded on coverslips coated with poly-
 
l
 
-lysine. The
cells were treated for 30 min at 37
 
8
 
C with 200 nM SDF-1
 
a
 
,
RANTES, or RANTES(9-68). After incubation with ligands,
the cells were washed and fixed for 20 min in 3.7% paraformalde-
hyde-PBS, washed again in PBS, mounted in 133 mg/ml Mow-
iol (HOECHST), 33% glycerol, 133 mM Tris-HCl, pH 8.5, and
analyzed by confocal microscopy. After fixation, CEM cells were
incubated for 15 min in PBS and 0.1 M glycine to quench free al-
dehydes, and permeabilized by incubation with 0.05% saponin in
PBS supplemented with 0.2% BSA for 15 min. The cells were
then incubated for 45 min at room temperature with the anti-
CXCR4 monoclonal antibody 12G5 (24), a kind gift of Dr. J.
Hoxie (University of Pennsylvania Medical Center, Philadelphia,
PA), and labeled with a secondary, fluorescein-conjugated (FITC)
goat anti–mouse IgG antibody. For staining with iron-loaded hu-
man transferrin coupled to rhodamine (Tf-RITC), cells were de-
prived of transferrin for 30 min at 37
 
8
 
C in serum-free medium,
and then incubated for 30 min at 37
 
8
 
C with Tf-RITC along with
the appropriate chemokine or antagonist. Confocal laser scanning
microscopy and double-fluorescence analysis were performed
with a TCS4D confocal microscope (Leica, Nussloch, Germany)
interfaced with Argon/Krypton lasers. Simultaneous double-fluo-
 
rescence acquisitions were performed using the 488- and the
568-nm laser lines to excite FITC and RITC dyes using a 100
 
3
 
oil immersion Plan APO objective (NA 
 
5
 
 1.4). The fluorescence
was selected with the appropriate double-fluorescence dichroic
mirror and band pass filters, and measured with blue-green and
red side sensitive one photomultipliers.
 
Cell Transfection, Flow Cytometry Analysis and Recording of Intra-
cellular Ca
 
2
 
1
 
 ([Ca
 
2
 
1
 
]
 
i
 
) Changes.
 
Cells (8 
 
3
 
 10
 
6
 
) were resuspended
in Dulbecco’s modified Eagle’s medium, supplemented with 10%
FCS, 1–4 
 
m
 
g of the appropriate DNA expression vectors, and 12 
 
m
 
g
of a non-coding carrier DNA plasmid. Electroporation was per-
formed in 4-mm cuvettes at 220 V, 960 
 
m
 
F in a Bio-Rad Gene
Pulser. For flow cytometry, cells (5 
 
3
 
 10
 
5
 
) were incubated for 1 h
with anti-CXCR4 and subsequently labeled with a secondary,
PE-conjugated goat anti–mouse IgG antibody (Southern Bio-
technology, Birmingham, AL). After staining, cells were fixed in
1% paraformaldehyde-PBS containing 0.2% BSA and CXCR4 ex-
pression was analyzed with a FACScan
 
Ò
 
 cytofluorometer (Becton
Dickinson, Mountain View, CA). CXCR4 expression in mono-
cyte-depleted PBMC was studied on gated CD4
 
1
 
 cells. The cells
were incubated with anti-CXCR4 and labeled with the PE-con-
jugated secondary antibody followed by a FITC-conjugated anti-
CD4 antibody (Leu3a; Becton Dickinson). Real-time recordings
of [Ca
 
2
 
1
 
]
 
i
 
 were performed with an IMSTAR imaging system in
Fura-2 loaded cells as described previously (25). To remove cell-
bound SDF-1
 
a
 
, the cells were exposed for 1 min at 37
 
8
 
C to an
acid buffer, pH 3.0, consisting of 50 mM glycine and 100 mM
NaCl buffer (10
 
6
 
 cells per ml), and then centrifuged and resus-
pended into the appropriate medium (17).
 
Viral Infections.
 
U373-CD4 LTR
 
lacZ
 
 cells transfected with
either the CXCR4 WT or CXR4 
 
D
 
Cyt vectors were seeded in
microtiter plates (10
 
4
 
 cells per well) in a final volume of 200 
 
m
 
l.
24 h after transfection the cells were incubated with infectious su-
pernatants obtained from MT4 cell cultures infected with the
HIV-1 molecular clone NL4-3 (HIV-1
 
NL4-3
 
) (40 ng of HIV-1p24
per well). SDF-1
 
a
 
 or RANTES were added to the cells 20 min
before infection and were present during the whole culture pe-
riod. Cultures were carried out in triplicate. Infected cells were
identified by staining for 
 
b
 
-galactosidase. HIV-1(
 
D
 
Env)G is a pseu-
dotyped HIV-1
 
NL4-3
 
 variant with a replacement of the Env pro-
tein with the Env (G) glycoprotein of the vesicular stomatitis virus
(VSV). To generate infectious supernatants of HIV-1(
 
D
 
Env)G,
plasmids encoding the HIV-1
 
NL4-3 
 
proviral DNA deleted of the
 
env
 
 gene and the Env (G) glycoprotein of VSV were cotrans-
fected in HeLa cells. U373-CD4 LTRlacZ cells were infected
with HIV-1(
 
D
 
Env)G infectious supernatants (4 ng of HIV-1 p24
per well).
 
Results and Discussion
 
Chemokine Receptor Internalization.
 
After incubation with
SDF-1
 
a
 
, surface expression of CXCR4 in CEM cells (Fig.
1 a), monocyte-depleted PBMC (Fig. 1 
 
b
 
), or HeLa cells
(Fig. 1 c), was analyzed by flow cytometry using anti-
CXCR4. Before analysis, SDF-1
 
a
 
–treated cells were washed
in an acidic glycine buffer, a procedure previously adopted
to dissociate IL-8 from its receptors (17). The washing re-
moved receptor-bound SDF-1
 
a
 
 that could interfere with
the binding of anti-CXCR4 (data not shown). As shown
in Fig. 1, 
 
a–c
 
 SDF-1
 
a
 
 induced a profound decrease of cell
surface receptors in all three cell types. The downregula-
tion of CXCR4 was specific for SDF-1
 
a
 
 and was not ob- 
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served when the cells were treated with RANTES, which
does not bind CXCR4 (Fig. 1, 
 
a–c
 
). Upon treatment with
RANTES CXCR4 expression was comparable to that of
control cells that were not exposed to a chemokine but
washed with the glycine buffer. This indicates that the
washing with the acidic buffer did not modify the expres-
sion of CXCR4 or the ability of anti-CXCR4 to recognize
surface receptors.
CXCR4 downregulation induced by SDF-1
 
a
 
 was con-
centration dependent, and the maximal effect was reached
at 200 nM as shown in CEM cells (Fig. 1 
 
d
 
). Pretreatment
of the cells with pertussis toxin under conditions that com-
pletely inhibited Ca
 
2
 
1
 
 mobilization by SDF-1
 
a
 
 (data not
shown) did not prevent the decrease of cell surface receptor
expression (Fig. 1 
 
d
 
). This indicates that the observed down-
regulation of CXCR4 was not dependent on signaling by
G
 
i
 
-proteins. The downregulation was rapid. It was already
detectable 5 min after addition of SDF-1
 
a
 
 and progressed
for 
 
z
 
20 min (Fig. 1 
 
e
 
). Further incubation in the presence
of chemokine up to 60 min did not lead to an additional
decrease of the number of surface-detectable receptors.
To investigate the fate of CXCR4 after downregulation,
CEM cells treated with SDF-1
 
a
 
 and washed with the acidic
buffer were further incubated at 37
 
8
 
C in the absence of the
chemokine. Surface re-expression of CXCR4 was detected
within the first 15 min (Fig. 1 
 
f
 
), but no further increase in
receptor density was observed for up to 60 min. Re-expres-
sion was not dependent on de novo protein synthesis since
it was not affected by the presence of cycloheximide. These
results suggest that after binding of SDF-1a CXCR4 is in-
ternalized and re-expressed at the cell surface by a recycling
mechanism. Recycling is likely to account for the fact that
the expression of CXCR4 never decreased below 10–25%
even at high SDF-1a concentrations and prolonged incu-
bation times.
Ligand-induced endocytosis of CXCR4 was assessed in
CEM cells by confocal laser scanning microscopy. In the
absence of chemokine, CXCR4 was mainly detected at the
cell surface. Exposure to SDF-1a induced a dramatic redis-
tribution of the staining that is consistent with the intracel-
lular accumulation of the receptor. This effect was specific
for SDF-1a and was not observed when the cells were ex-
posed to RANTES (Fig. 2 a, CXCR4). The subcellular
distribution of internalized CXCR4 was studied by simul-
taneous labeling with anti-CXCR4 (green) and human trans-
ferrin coupled to rhodamine (Tf-RITC, red) which is taken
up into early endosomes. As shown in Fig. 2 a (CXCR41
Tf-RITC), both markers were largely colocalized, as re-
vealed by the yellow spots, indicating a significant accumu-
lation of internalized CXCR4 in early endosomes. Similar
experiments were performed to study the ligand-induced
endocytosis of CCR5. Since anti-CCR5 antibodies for im-
munodetection were not available, we used cell clones per-
manently expressing CCR5 fused to the fluorescence marker
GFP (CHO-CCR5-GFP and HeLa-CCR5-GFP). Addi-
tion of RANTES to either clone induced receptor endocy-
tosis (Figs. 2, b and c, CCR5). Colocalization with Tf-
RITC, in analogy to the above experiments, show that
CCR5-GFP accumulates preferentially in early endosomes,
as indicated by the clusters of yellow spots in the juxtanu-
Figure 1. Effect of SDF-1a
stimulation on CXCR4 surface
expression. CEM lymphoblastoid
T cells (a), monocyte-depleted
PBMC (b), or HeLa cells (c) were
treated for 40 min at 37˚C with
200 nM SDF-1a, 200 nM
RANTES, or medium alone
(UNTREATED). The cells were
then washed with acidic glycine
buffer, labeled at 4˚C with anti-
CXCR4 and a PE-conjugated
secondary antibody, and ana-
lyzed by flow cytometry. In b,
analysis was performed on gated
CD41  cells (FITC-conjugated
anti-CD4). Control cells (CTRL)
were labeled with the secondary
antibody only. (d) Dependence
of CXCR4 downregulation on
SDF-1a concentration. CEM
cells were incubated for 40 min
at 378C with increasing concen-
trations of SDF-1a, and surface
expression of CXCR4 was de-
termined. PTX: before incuba-
tion with SDF-1a, the cells were
treated with 5 mg/ml pertussis
toxin for 90 min. (e) Time course of CXCR4 downregulation. Cells were pre-incubated at 48C for 60 min with 200 nM SDF-1a or RANTES. After
washing, cells were cultured at 378C for the indicated times in the absence of chemokines. ( f ) Re-expression of CXCR4. The cells were incubated at
37˚C for 40 min with 200 nM SDF-1a in the presence or absence of 100 mg/ml cycloheximide, washed in acidic glycine buffer and further cultured for
up to 60 min at 378C with or without cycloheximide in the absence of SDF-1a. (d–f) Relative surface expression of CXCR4 was analyzed by flow cy-
tometry as described for a.142 CXCR4 Internalization Inhibits HIV-1 Entry
Figure 2. Internalization of
CXCR4 (a) and CCR5 (b and c)
were analyzed by confocal laser
scanning microscopy in CEM
(a), CHO-CCR5-GFP (b), and
HeLa-CCR5-GFP (c) cells after
exposure to 200 nM SDF-1a,
RANTES or RANTES(9-68)
for 30 min at 378C. –, untreated
cells; CXCR4, cells labeled with
anti-CXCR4 and a FITC-conju-
gated secondary antibody; CCR5,
autofluorescence of CCR5-
GFP; CXCR41, Tf-RITC and
CCR51Tf-RITC, simultaneous
detection of Tf-RITC (red) and
either CXCR4 or CCR5-GFP
(green). Yellow spots indicate
colocalization of chemokine re-
ceptor and Tf-RITC.143 Amara et al.
clear region (Fig. 2 b, CCR51Tf-RITC). The occurrence
of internalized CXCR4 or CCR5 that do not colocalize with
Tf-RITC (green spots) might reflect the transfer of receptors
to late endosomes. The CCR5 antagonist RANTES(9-68),
which was previously shown to block infection by mono-
cytotropic HIV isolates despite its inability to elicit Ca21 mo-
bilization and chemotaxis (16), was as effective as RANTES as
inducer of CCR5-GFP internalization (Fig. 2, b and c).
This is in agreement with the observation that the SDF-
1a–dependent internalization of CXCR4 was not affected
by pertussis toxin and confirms that chemokine receptor
endocytosis does not require signaling via Gi-proteins.
COOH-terminally Truncated Receptor. It was previously
shown that endocytosis of IL-8 receptors requires an intact
COOH-terminal cytoplasmic domain (26). The role of the
corresponding domain of CXCR4 was, therefore, investi-
gated using HeLa cells that were transiently transfected
with a vector expressing a CXCR4 cDNA deleted of the
last 41 amino acids (CXCR4 DCyt). HeLa cells were cho-
sen because they constitutively express CXCR4, and allow
to perform simultaneous analysis of SDF-1a effects on en-
dogenous and transfected CXCR4. Cotransfection of either
CXCR4 WT or CXCR4 DCyt with a GFP reporter vec-
tor permitted to distinguish transfected from nontransfected
Figure 3. Effect of deletion of
the COOH-terminal cytoplas-
mic domain of CXCR4. (a)
HeLa cells were transiently trans-
fected with the CXCR4 WT or
the CXCR4 DCyt expression
vector, along with a plasmid en-
coding the reporter gene GFP
(pEGFP). 24 h later, the cells
were incubated for 45 min at
378C in the presence or absence
of 300 nM SDF-1a, labeled with
anti-CXCR4, and analyzed by
flow cytometry. Expression of
GFP allows to distinguish trans-
fected (GFP1) and nontransfected
(GFP2) cells. After transfection
with CXCR4 WT or CXCR4
Dcyt, SDF-1a–dependent down-
regulation of the endogenous
and the transfected receptor were
monitored in GFP2 and GFP1
cells, respectively. (–) HeLa cells
were transiently transfected with
the CXCR4 WT or CXCR4
DCyt expression vector, along
with the pEGFP plasmid. 24 h
later, the cells were incubated for
45 min at 378C with 300 nM
SDF-1a or with 20 ng/ml PMA,
labeled with anti-CXCR4 and
surface expression of CXCR4
was analyzed by flow cytometry
in GFP1 cells. (c) CHO cells
were transfected with either the
CXCR4 WT or the CXCR4
DCyt expression vectors and
were loaded 48 h later with
Fura-2. CHO control cells were
transfected with vector DNA
alone (pcDNA3). Recordings of
[Ca21]i changes after stimulation
with 200 nM of SDF-1a are
shown.144 CXCR4 Internalization Inhibits HIV-1 Entry
cells. Incubation with SDF-1a induced a profound down-
regulation of CXCR4 WT, but did not affect the surface
expression of the COOH-terminally truncated receptor,
CXCR4 DCyt (Fig. 3, a and b). As expected the endoge-
nous CXCR4, in nontransfected cells which are identified
by the lack of GFP fluorescence, was also markedly down-
regulated by SDF-1a (Fig. 3 a). PMA had a similar effect.
It downregulated CXCR4 WT (Fig. 3 b) as well as the en-
dogenous CXCR4 (not shown), but not CXCR4 DCyt
(Fig. 3 b). These results are in agreement with a previous
report showing downregulation of CXCR4 by PMA in
human T lymphocytes (27), and suggest that phosphoryla-
tion of serines and threonines in the COOH-terminal re-
gion are involved in internalization. It has been shown that
phosphorylation of the COOH-terminal domain is essen-
tial for arrestin-mediated uptake of seven-transmembrane
domain receptors via clathrin-coated pits (28, 29).
CHO cells transiently expressing either CXCR4 WT or
CXCR4 DCyt were used to assess receptor signaling. As
shown by the changes in the cytosolic free Ca21 concentra-
tion in response to SDF-1a, the wild-type and the COOH-
terminally truncated receptor were equally capable of elicit-
ing a response indicating that the COOH-terminal domain of
CXCR4 is not required for Gi-protein coupling (Fig. 3 c).
This result is in agreement with a previous report indicating
that deletion of the COOH-terminal domain of the IL-8 re-
ceptors did not affect signal transduction (26).
HIV Entry. The capacity of the CXCR4 DCyt mole-
cule to act as coreceptor for HIV-1 entry was studied in the
human, U373-CD4 LTRlacZ astrocytoma cell clone which
does not express endogenous CXCR4 and carries an inte-
grated b-galactosidase reporter gene driven by the HIV-1
LTR. Both CXCR4 DCyt and the wild-type receptor
could be expressed with similar efficiency, as assessed by
FACSÒ analysis and by scoring of HIV-1 infected cells. It was,
therefore, possible to study the role of receptor occupancy
and receptor internalization as mechanisms for the HIV sup-
pressive activity of SDF-1a, using U373-CD4 LTRlacZ
cells that were transiently transfected with CXCR4 DCyt
or CXCR4 WT. HIV infection was inhibited by SDF-1a
in a concentration-dependent manner in cells expressing
the truncated or the wild-type receptor, confirming that
both bind the chemokine and can act as HIV coreceptors.
However, the efficacy of SDF-1a as an inhibitor of infec-
tion was markedly lower in cells expressing CXCR4 DCyt
(Fig. 4). In cells with the wild-type receptor SDF-1a has
two effects that decrease infectability, competition for HIV
binding and a drastic reduction of receptor numbers by
rapid endocytosis. Both mechanisms operate at the same
time suggesting that the full antiviral effects of SDF-1a is a
combination of competition for receptor binding by the
virus and receptor endocytosis. In cells bearing the COOH-
terminally truncated receptor downregulation cannot oc-
cur, and protection by SDF-1a is less efficient because re-
ceptor density remains high. Findings similar to those in
the U373-CD4 LTRlacZ glioblastoma cells were obtained
in HeLa-CD4 LTRlacZ cells, where SDF-1a was less effi-
cient as an inhibitor of HIV replication when CXCR4
DCyt was expressed (data not shown). The selectivity of
SDF-1a as an inhibitor of CXCR4-dependent infection is
indicated by two lines of evidence. RANTES was unable
to block entry of the CXCR4-dependent HIVNL4-3 viral
clone in U373-CD4 LTRlacZ cells, and SDF-1a did not
inhibit infection by an Env-deleted HIVNL4-3 clone pseudo-
typed with the Env (G) protein of VSV (Fig. 4).
We have shown that CXCR4 and CCR5 are rapidly
down-regulated by endocytosis when the cells are exposed
to the appropriate chemokine ligand. The mechanism of
receptor internalization was ligand dependent, but was
clearly dissociable from chemokine-induced Gi-protein sig-
naling. In fact, CXCR4 internalization was not affected by
Gi-protein inactivation with pertussis toxin, and CCR5 in-
ternalization was induced by the antagonist RANTES(9-
68) which binds to CCR5 but does not activate Gi-pro-
teins. On the other hand, no internalization was observed
in cells expressing CXCR4 deleted of its COOH-terminal,
cytoplasmic domain, although Gi protein–dependent [Ca21]i
changes were not impaired.
Deletion of the COOH-terminal domain does not affect
the ability of CXCR4 to act as a coreceptor for HIV entry.
If receptor endocytosis is prevented by truncation, how-
ever, SDF-1a is clearly less efficient as an inhibitor of HIV
Figure 4. SDF-1a–dependent inhibition of HIV infection in cells ex-
pressing wild-type or COOH-terminally truncated CXCR4. U373-CD4
LTRlacZ were transfected with either CXCR4 WT or CXCR4 DCyt
expression vector, plated in 96-well plates (104 cells per well) and infected
with the HIV-1NL4-3 strain or the pseudotyped HIV-1(Denv)G, in the
presence of the indicated concentrations of SDF-1a or RANTES. HIV-
1(Denv)G–infected cells were treated with 500 nM SDF-1a. Cell cultures
were carried out in triplicates. Surface expression of CXCR4 WT or
CXCR4  DCyt was assessed 24 h after transfection by FACSÒ analysis and
amounted to 482 and 533 fluorescence units, respectively. HIV infection
was revealed 24 h later by staining for b-galactosidase activity and scoring
of positive cells. The numbers of HIV-infected cells per well in the ab-
sence of chemokines were 168 and 232 (mean of five experiments) for
cultures transfected with CXCR4 WT and CXCR4 DCyt, respectively.
In cultures infected with HIV-1(Denv)G the average number of infected
cells per well was 280. Shown are the percentages of infected cells in the
presence of chemokines. Infection with HIV-1NL4-3 or HIV-1(Denv)G in
the absence of chemokines was set to 100%.145 Amara et al.
replication. Our present results show that the ability of the
receptor to internalize is not required for HIV entry, but
may contribute to the HIV suppressive effect of chemokine
ligands by reducing the density of coreceptors. Viral entry
is a complex phenomenon in which gp120 attachment to
CD4 creates a high-affinity binding site for the coreceptor,
leading to membrane fusion (30, 31). Chemokines thus ap-
pear to exert two types of anti-HIV activities, competition
for HIV-1 binding, and downregulation of coreceptor sur-
face expression. Both processes are functionally linked since
receptor occupancy triggers internalization, and are likely
to synergize with each other.
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